Docosahexaenoic Acid (DHA) Supplements For Breast-Feeding Mothers Is Good For Premature Infants.
Very too early infants have higher levels of DHA - an omega-3 fatty acid that's basic to the improvement and development of the brain - when their breast-feeding mothers believe DHA supplements, Canadian researchers have found. Researchers say a deficiency in DHA (docosahexaenoic acid) is common in very preterm infants, possibly because the ordinary diets of many in the or breast-feeding women lack the essential fatty acid, which is found in cold water fatty fish and fish lubricator supplements.
The study included breast-feeding mothers of 12 infants born at 29 weeks gestation or earlier. The mothers were given high-priced doses of DHA supplements until 36 weeks after conception. The mothers and babies in this intervention series were compared at date 49 to a control group of mothers of very preterm infants who didn't take DHA supplements.
The levels of DHA in the knocker milk of mothers who took DHA supplements were nearly 12 times higher than in the draw off of mothers in the control group. Infants in the intervention group received about seven times more DHA than those in the hold back group. Plasma DHA concentrations in mothers and babies in the intervention league were two to three times higher than those in the control group.
So "Our study has shown that supplementing mothers is a usable and effective way of providing DHA to low birthweight premature infants," review author Dr Isabelle Marc, an assistant professor in the pediatrics department at Laval University in Quebec, said in a item release. The DHA content in the breast drain of mothers who don't consume fish during the breast-feeding period is probably insufficient, according to Marc.
Saturday, 18 January 2020
Use Of Finasteride Reduces Alcohol Consumption
Use Of Finasteride Reduces Alcohol Consumption.
Some men who use finasteride (Propecia) to balm Donnybrook baldness may also be drinking less alcohol, a new study suggests June 2013. Among the potency side effects of the hair-restoring drug are a reduced sex drive, concavity and suicidal thoughts. And it's men who have sexual side effects who also appear to want to guzzle less, the researchers report. "In men experiencing persistent sexual side junk despite stopping finasteride, two-thirds have noticed drinking less alcohol than before taking finasteride," said analysis author Dr Michael Irwig, an assistant professor of medicine at George Washington University School of Medicine and Health Sciences in Washington, DC.
Although it isn't obvious why the medication might have this effect, Irwig thinks the dull may alter the brain's chemistry. "Finasteride interferes with the brain's capability to make certain hormones called neurosteroids, which are likely linked to drinking alcohol. For younger men contemplating the use of finasteride for manly pattern hair loss, they should carefully up the modest cosmetic benefits of less hair loss versus some of the serious risks".
The report was published online June 13 in the almanac Alcoholism: Clinical and Experimental Research. "The biggest object to with this finding is that it is naturalistic rather than a controlled study so cause-and-effect is hard to establish," said James Garbutt, a professor of psychiatry at the University of North Carolina at Chapel Hill. "This is more of a cloud on the vista than a clear-cut effect".
If these findings are confirmed it suggests there may be a subgroup of people, it is possible that identifiable by their exposure of sexual side effects, who will experience reductions in alcohol consumption who was not involved with the study. "Based on the consumption levels reported in the paper, this denizens would be considered social drinkers and not delinquent drinkers".
Some men who use finasteride (Propecia) to balm Donnybrook baldness may also be drinking less alcohol, a new study suggests June 2013. Among the potency side effects of the hair-restoring drug are a reduced sex drive, concavity and suicidal thoughts. And it's men who have sexual side effects who also appear to want to guzzle less, the researchers report. "In men experiencing persistent sexual side junk despite stopping finasteride, two-thirds have noticed drinking less alcohol than before taking finasteride," said analysis author Dr Michael Irwig, an assistant professor of medicine at George Washington University School of Medicine and Health Sciences in Washington, DC.
Although it isn't obvious why the medication might have this effect, Irwig thinks the dull may alter the brain's chemistry. "Finasteride interferes with the brain's capability to make certain hormones called neurosteroids, which are likely linked to drinking alcohol. For younger men contemplating the use of finasteride for manly pattern hair loss, they should carefully up the modest cosmetic benefits of less hair loss versus some of the serious risks".
The report was published online June 13 in the almanac Alcoholism: Clinical and Experimental Research. "The biggest object to with this finding is that it is naturalistic rather than a controlled study so cause-and-effect is hard to establish," said James Garbutt, a professor of psychiatry at the University of North Carolina at Chapel Hill. "This is more of a cloud on the vista than a clear-cut effect".
If these findings are confirmed it suggests there may be a subgroup of people, it is possible that identifiable by their exposure of sexual side effects, who will experience reductions in alcohol consumption who was not involved with the study. "Based on the consumption levels reported in the paper, this denizens would be considered social drinkers and not delinquent drinkers".
New Research Of Children's Autism
New Research Of Children's Autism.
An speculative drug for autism did not pick up levels of lethargy and social withdrawal in children who took it, but it did show some other benefits, a budding study finds in May 2013. Children on arbaclofen did improve on an overall measure of autism starkness when compared to kids taking an inactive placebo, said lead researcher Dr Jeremy Veenstra-VanderWeele, an associate professor of psychiatry, pediatrics and pharmacology at Vanderbilt University. He is to present the findings Thursday at the International Meeting for Autism Research (IMFAR) in Spain.
One of 88 children in the United States is now diagnosed with an autism spectrum disorder, the parasol call for complex brain phenomenon disorders marked by problems in social interaction and communication. Veenstra-VanderWeele focused on evaluating the public improvement with the drug because earlier research had suggested it could help. However, one of the earlier studies did not analogize the drug to a placebo, but simply measured improvement in those who took the drug.
In the new study, Veenstra-VanderWeele and his line-up assigned 150 people with autism, aged 5 to 21, to take the cure-all or a placebo, without knowing which group they were in, for eight weeks. The participants had been diagnosed with autistic disorder, Asperger's syndrome or another interconnected condition known as pervasive developmental disorder. In all, 130 finished the study.
An speculative drug for autism did not pick up levels of lethargy and social withdrawal in children who took it, but it did show some other benefits, a budding study finds in May 2013. Children on arbaclofen did improve on an overall measure of autism starkness when compared to kids taking an inactive placebo, said lead researcher Dr Jeremy Veenstra-VanderWeele, an associate professor of psychiatry, pediatrics and pharmacology at Vanderbilt University. He is to present the findings Thursday at the International Meeting for Autism Research (IMFAR) in Spain.
One of 88 children in the United States is now diagnosed with an autism spectrum disorder, the parasol call for complex brain phenomenon disorders marked by problems in social interaction and communication. Veenstra-VanderWeele focused on evaluating the public improvement with the drug because earlier research had suggested it could help. However, one of the earlier studies did not analogize the drug to a placebo, but simply measured improvement in those who took the drug.
In the new study, Veenstra-VanderWeele and his line-up assigned 150 people with autism, aged 5 to 21, to take the cure-all or a placebo, without knowing which group they were in, for eight weeks. The participants had been diagnosed with autistic disorder, Asperger's syndrome or another interconnected condition known as pervasive developmental disorder. In all, 130 finished the study.
Some Types Of Antidepressants Increase The Risk Of Miscarriage
Some Types Of Antidepressants Increase The Risk Of Miscarriage.
Women who engage a steady class of antidepressants during pregnancy may increase their risk of having a frustration by 68 percent, Canadian researchers report. Antidepressant use is common during pregnancy, with up to 3,7 percent of women taking the drugs during the essential trimester. Stopping treatment can lead to a return of depression and other symptoms, and earlier studies of the medications' effects on the fetus have been small and had contradictory results.
But the Canadian case-control mull over on more than 5000 women found that by controlling for other factors associated with miscarriage, taking antidepressants known as eclectic serotonin reuptake inhibitors (SSRIs) during pregnancy led to an increased risk of miscarriage. Up to 20 percent - or one baggage out of five - will suffer a miscarriage for various reasons during pregnancy. But the inspect results suggest that SSRIs as a class increase that risk, according to lead researcher Anick Berard, an confederate professor at the University of Montreal.
The results "are highly robust given the big-hearted number of users studied". In addition the study makes clear that the drugs, rather than the mothers' despondency and anxiety, are associated with an increased risk for miscarriage.
However, the author of an accompanying editorial famed that the finding is far from definitive. "This is an association, not a cause," said Adrienne Einarson, assistant headman of the Motherisk Program at the Hospital for Sick Children in Toronto. "We still don't know if it's the impression or the drug".
Also, the risk uncovered by the study is a very small one. "Less than twice as many women had miscarriages in the classify with antidepressants as those who did not take antidepressants. It's a very small risk indeed, and it's not a common sense to stop taking an antidepressant if you need it".
Women who engage a steady class of antidepressants during pregnancy may increase their risk of having a frustration by 68 percent, Canadian researchers report. Antidepressant use is common during pregnancy, with up to 3,7 percent of women taking the drugs during the essential trimester. Stopping treatment can lead to a return of depression and other symptoms, and earlier studies of the medications' effects on the fetus have been small and had contradictory results.
But the Canadian case-control mull over on more than 5000 women found that by controlling for other factors associated with miscarriage, taking antidepressants known as eclectic serotonin reuptake inhibitors (SSRIs) during pregnancy led to an increased risk of miscarriage. Up to 20 percent - or one baggage out of five - will suffer a miscarriage for various reasons during pregnancy. But the inspect results suggest that SSRIs as a class increase that risk, according to lead researcher Anick Berard, an confederate professor at the University of Montreal.
The results "are highly robust given the big-hearted number of users studied". In addition the study makes clear that the drugs, rather than the mothers' despondency and anxiety, are associated with an increased risk for miscarriage.
However, the author of an accompanying editorial famed that the finding is far from definitive. "This is an association, not a cause," said Adrienne Einarson, assistant headman of the Motherisk Program at the Hospital for Sick Children in Toronto. "We still don't know if it's the impression or the drug".
Also, the risk uncovered by the study is a very small one. "Less than twice as many women had miscarriages in the classify with antidepressants as those who did not take antidepressants. It's a very small risk indeed, and it's not a common sense to stop taking an antidepressant if you need it".
Friday, 17 January 2020
Doctors Recommend That Pregnant Women Have To Make A Flu Shot
Doctors Recommend That Pregnant Women Have To Make A Flu Shot.
Pregnant women were urged to get a flu launch during the 2009 H1N1 pandemic, and further display supports that advice. Norwegian researchers have found that vaccination in pregnancy was safe for origin and child, and that fetal deaths were more common among unvaccinated moms-to-be. Influenza is a serious intimation to a pregnant woman and her unborn child, said Dr Camilla Stoltenberg, director vague of the Norwegian Institute of Public Health in Oslo, lead researcher of the new study. "Our look at indicates that influenza during pregnancy was a risk factor for stillbirth during the pandemic in 2009".
And "We judge no indication that pandemic vaccination in the second or third trimester increased the risk of stillbirth". With this year's flu pummeling many folk across the United States, experts reveal the best way a pregnant woman can protect her unborn baby from flu complications is by getting a flu shot. "In adding to protecting the mother against severe influenza, the vaccine protects the fetus and the lassie in the first months after birth, when the child is too young to be vaccinated".
The US Centers for Disease Control and Prevention recommends a flu spot for everyone over 6 months of age. Besides replete women, the CDC says the elderly and anyone with a chronic condition such as asthma or diabetes are especially vulnerable to infection.
For the study, published Jan 16, 2013 in the New England Journal of Medicine, Stoltenberg's crew cool data on more than 117000 women in Norway who were pregnant between 2009 and 2010 - the take of the H1N1 pandemic. The investigators found the rate of fetal deaths was almost five per 1000 women.
Pregnant women were urged to get a flu launch during the 2009 H1N1 pandemic, and further display supports that advice. Norwegian researchers have found that vaccination in pregnancy was safe for origin and child, and that fetal deaths were more common among unvaccinated moms-to-be. Influenza is a serious intimation to a pregnant woman and her unborn child, said Dr Camilla Stoltenberg, director vague of the Norwegian Institute of Public Health in Oslo, lead researcher of the new study. "Our look at indicates that influenza during pregnancy was a risk factor for stillbirth during the pandemic in 2009".
And "We judge no indication that pandemic vaccination in the second or third trimester increased the risk of stillbirth". With this year's flu pummeling many folk across the United States, experts reveal the best way a pregnant woman can protect her unborn baby from flu complications is by getting a flu shot. "In adding to protecting the mother against severe influenza, the vaccine protects the fetus and the lassie in the first months after birth, when the child is too young to be vaccinated".
The US Centers for Disease Control and Prevention recommends a flu spot for everyone over 6 months of age. Besides replete women, the CDC says the elderly and anyone with a chronic condition such as asthma or diabetes are especially vulnerable to infection.
For the study, published Jan 16, 2013 in the New England Journal of Medicine, Stoltenberg's crew cool data on more than 117000 women in Norway who were pregnant between 2009 and 2010 - the take of the H1N1 pandemic. The investigators found the rate of fetal deaths was almost five per 1000 women.
Experts Urge Parents To Buy Kids Sunglasses Against Ultraviolet Radiation
Experts Urge Parents To Buy Kids Sunglasses Against Ultraviolet Radiation.
With May designated as UV awareness month, experts are occupation on parents to give particular heed to the safety of their children's eyes this summer. Although eye keeping is a concern for people of all ages, Prevent Blindness America, the nation's oldest eye healthiness and safety organization, warns that children are particularly vulnerable to the harmful ultraviolet A and B (UVA and UVB) price that can accompany sun exposure. For one, children in the main spend more time in the sun, the group noted.
In addition, the organization highlights the American Optometric Association's cautionary judgement that the lenses of young eyes are more transparent than that of adults, risking retinal location to a greater degree of short wavelength light. "We need to remember to take care of our eyes from UV every day of the year," Hugh R Parry, president and CEO of Prevent Blindness America, said in a communication release. "UV rays reflecting off the water, sand, pavement and even snow are uncommonly dangerous. We can encourage our children to wear the proper ogle protection by leading by example".
UV exposure has been linked to the onset of cataracts, macular degeneration and a major array of eye health issues, the experts noted. Prevent Blindness America advises that each and every one who goes out in the sun should wear sunglasses that block out 99 percent to 100 percent of both UVA and UVB dispersal - noting that sunglasses without such protection can actually cause the pupils to dilate, thereby doing more hurt than good. A wide-brimmed hat or cap also offers some measure of eye protection, the batch suggested.
With specific respect to children, Prevent Blindness America further encourages parents to make safe that sunglasses fit their child's face properly and shields the sun's rays from all directions. The league points out that wrap-around sunglasses might be optimal in the later regard, because they additionally defend the skin immediately surrounding a child's eyes. Sunglasses, they note, should always be composed of impact-resistant polycarbonates, rather than glass, and should be scratch-free.
With May designated as UV awareness month, experts are occupation on parents to give particular heed to the safety of their children's eyes this summer. Although eye keeping is a concern for people of all ages, Prevent Blindness America, the nation's oldest eye healthiness and safety organization, warns that children are particularly vulnerable to the harmful ultraviolet A and B (UVA and UVB) price that can accompany sun exposure. For one, children in the main spend more time in the sun, the group noted.
In addition, the organization highlights the American Optometric Association's cautionary judgement that the lenses of young eyes are more transparent than that of adults, risking retinal location to a greater degree of short wavelength light. "We need to remember to take care of our eyes from UV every day of the year," Hugh R Parry, president and CEO of Prevent Blindness America, said in a communication release. "UV rays reflecting off the water, sand, pavement and even snow are uncommonly dangerous. We can encourage our children to wear the proper ogle protection by leading by example".
UV exposure has been linked to the onset of cataracts, macular degeneration and a major array of eye health issues, the experts noted. Prevent Blindness America advises that each and every one who goes out in the sun should wear sunglasses that block out 99 percent to 100 percent of both UVA and UVB dispersal - noting that sunglasses without such protection can actually cause the pupils to dilate, thereby doing more hurt than good. A wide-brimmed hat or cap also offers some measure of eye protection, the batch suggested.
With specific respect to children, Prevent Blindness America further encourages parents to make safe that sunglasses fit their child's face properly and shields the sun's rays from all directions. The league points out that wrap-around sunglasses might be optimal in the later regard, because they additionally defend the skin immediately surrounding a child's eyes. Sunglasses, they note, should always be composed of impact-resistant polycarbonates, rather than glass, and should be scratch-free.
Another Genetic Cause Of Alzheimer's Disease
Another Genetic Cause Of Alzheimer's Disease.
Researchers have discovered that the variation of a gene associated with beginning onset Alzheimer's may block a key recycling process demanded for brain cell survival - a finding that points the way to possible treatment for the disease. When it's working properly, this gene - called presenilin 1 (PS1) - performs a vital house-cleaning utility by helping brain cells digest unwanted, damaged and potentially toxic proteins.
But in its mutated form, the gene fails to supporter cells recycle these capability toxins, suggesting an explanation for the damage to the brain characteristic of Alzheimer's disease. "We hold we have identified the principal mechanism by which mutations of PS1 cause the most common genetic appear of Alzheimer's disease," study co-author Dr Ralph A Nixon, professor in the departments of psychiatry and chamber biology as well as director of NYU's Center of Excellence on Brain Aging and the Silberstein Alzheimer's Institute, said in a university rumour release.
And "Presently, no effective treatment exists to either unproductive or prevent the progression of Alzheimer's disease," added Nixon, also director of the Center for Dementia Research at the Nathan S Kline Institute for Psychiatric Research in New York City. "This unearthing has the the of identifying such a treatment".
Researchers have discovered that the variation of a gene associated with beginning onset Alzheimer's may block a key recycling process demanded for brain cell survival - a finding that points the way to possible treatment for the disease. When it's working properly, this gene - called presenilin 1 (PS1) - performs a vital house-cleaning utility by helping brain cells digest unwanted, damaged and potentially toxic proteins.
But in its mutated form, the gene fails to supporter cells recycle these capability toxins, suggesting an explanation for the damage to the brain characteristic of Alzheimer's disease. "We hold we have identified the principal mechanism by which mutations of PS1 cause the most common genetic appear of Alzheimer's disease," study co-author Dr Ralph A Nixon, professor in the departments of psychiatry and chamber biology as well as director of NYU's Center of Excellence on Brain Aging and the Silberstein Alzheimer's Institute, said in a university rumour release.
And "Presently, no effective treatment exists to either unproductive or prevent the progression of Alzheimer's disease," added Nixon, also director of the Center for Dementia Research at the Nathan S Kline Institute for Psychiatric Research in New York City. "This unearthing has the the of identifying such a treatment".
Surgery For Fibromyalgia Treatment
Surgery For Fibromyalgia Treatment.
An implanted cognizance that zaps the nerves at the nape of the neck - shown in operation in treating some people with migraines - may also help informality the ache of fibromyalgia, an ailment that causes widespread body pain and tenderness. A Belgian scientist treated reduced numbers of fibromyalgia patients with "occipital nerve stimulation," which rouses the occipital nerves just below the skin at the back of the neck using an implanted device. Dr Mark Plazier found that misery scores dropped for 20 of 25 patients using this device over six months and their quality of sustenance improved significantly.
And "There are only a few treatment options for fibromyalgia right now and the response to treatment is far from 100 percent, which implies there are a lot of patients still looking for daily to get a better life. This treatment might be an excellent privilege for them," said Plazier, a neurosurgeon at University Hospital Antwerp. But, "it is thorny to determine the impact of these findings on fibromyalgia patients, since larger trials are necessary".
Plazier is to present his digging this week at a meeting of the International Neuromodulation Society, in Berlin. Neuromodulation is a group of therapies that use medical devices to aid symptoms or restore abilities by altering nerve system function.
Research presented at systematic conferences has not typically been peer-reviewed or published and is considered preliminary.
An implanted cognizance that zaps the nerves at the nape of the neck - shown in operation in treating some people with migraines - may also help informality the ache of fibromyalgia, an ailment that causes widespread body pain and tenderness. A Belgian scientist treated reduced numbers of fibromyalgia patients with "occipital nerve stimulation," which rouses the occipital nerves just below the skin at the back of the neck using an implanted device. Dr Mark Plazier found that misery scores dropped for 20 of 25 patients using this device over six months and their quality of sustenance improved significantly.
And "There are only a few treatment options for fibromyalgia right now and the response to treatment is far from 100 percent, which implies there are a lot of patients still looking for daily to get a better life. This treatment might be an excellent privilege for them," said Plazier, a neurosurgeon at University Hospital Antwerp. But, "it is thorny to determine the impact of these findings on fibromyalgia patients, since larger trials are necessary".
Plazier is to present his digging this week at a meeting of the International Neuromodulation Society, in Berlin. Neuromodulation is a group of therapies that use medical devices to aid symptoms or restore abilities by altering nerve system function.
Research presented at systematic conferences has not typically been peer-reviewed or published and is considered preliminary.
Vitamin E Fights Against Diseases
Vitamin E Fights Against Diseases.
There might be some credible news in the wrangle against Alzheimer's disease: A new study suggests that a large daily dose of vitamin E might labourer slow progression of the memory-robbing illness. Alzheimer's patients given a "pharmacological" portion of vitamin E experienced slower declines in thinking and memory and required less caregiver metre than those taking a placebo, said Dr Maurice Dysken, lead author of a new study published Dec 31, 2013 in the Journal of the American Medical Association. "We found vitamin E significantly slowed the have a claim to of advance versus placebo," said Dysken, who is with the Geriatric Research Education and Clinical Center of the Minneapolis VA Health Care System.
Experts stressed, however, that vitamin E does not seem to wrestle the underlying cause of Alzheimer's and is in no nature a cure. The study involved more than 600 patients at 14 VA medical centers with kind to moderate Alzheimer's. Researchers separation the group into quarters, with each receiving a different therapy. One-quarter received a daily dose of 2000 supranational units (IU) of alpha tocopherol, a form of vitamin E That's a to some degree large dose; by comparison, a daily multivitamin contains only about 100 IUs of vitamin E.
The other sets of patients were given the Alzheimer's medication memantine, a syndication of vitamin E and memantine, or a placebo. People who took vitamin E merely experienced a 19 percent reduction in their annual estimate of decline compared to a placebo during the study's average 2,3 years of follow-up, the researchers said. In reasonable terms, this means the vitamin E group enjoyed a more than six-month hold up in the progression of Alzheimer's, the researchers said.
This delay could mean a lot to patients, the researchers said, noting that the settle experienced by the placebo group could translate into the complete loss of the ability to dress or bathe independently. The researchers also found that ancestors in the vitamin E group needed about two fewer hours of tribulation each day. Neither memantine nor the combination of vitamin E plus memantine showed clinical benefits in this trial. Therapy with vitamin E also appears to be safe, with no increased jeopardize of malady or death, the researchers found.
There might be some credible news in the wrangle against Alzheimer's disease: A new study suggests that a large daily dose of vitamin E might labourer slow progression of the memory-robbing illness. Alzheimer's patients given a "pharmacological" portion of vitamin E experienced slower declines in thinking and memory and required less caregiver metre than those taking a placebo, said Dr Maurice Dysken, lead author of a new study published Dec 31, 2013 in the Journal of the American Medical Association. "We found vitamin E significantly slowed the have a claim to of advance versus placebo," said Dysken, who is with the Geriatric Research Education and Clinical Center of the Minneapolis VA Health Care System.
Experts stressed, however, that vitamin E does not seem to wrestle the underlying cause of Alzheimer's and is in no nature a cure. The study involved more than 600 patients at 14 VA medical centers with kind to moderate Alzheimer's. Researchers separation the group into quarters, with each receiving a different therapy. One-quarter received a daily dose of 2000 supranational units (IU) of alpha tocopherol, a form of vitamin E That's a to some degree large dose; by comparison, a daily multivitamin contains only about 100 IUs of vitamin E.
The other sets of patients were given the Alzheimer's medication memantine, a syndication of vitamin E and memantine, or a placebo. People who took vitamin E merely experienced a 19 percent reduction in their annual estimate of decline compared to a placebo during the study's average 2,3 years of follow-up, the researchers said. In reasonable terms, this means the vitamin E group enjoyed a more than six-month hold up in the progression of Alzheimer's, the researchers said.
This delay could mean a lot to patients, the researchers said, noting that the settle experienced by the placebo group could translate into the complete loss of the ability to dress or bathe independently. The researchers also found that ancestors in the vitamin E group needed about two fewer hours of tribulation each day. Neither memantine nor the combination of vitamin E plus memantine showed clinical benefits in this trial. Therapy with vitamin E also appears to be safe, with no increased jeopardize of malady or death, the researchers found.
Parkinson's Disease Affects Humanity
Parkinson's Disease Affects Humanity.
A long-term use program may help calm depression in people with Parkinson's disease, according to a new, small study Dec 2013. Researchers looked at 31 Parkinson's patients who were randomly assigned to an "early start" heap that did an put to use program for 48 weeks or a "late start" group that worked out for 24 weeks. The program included three one-hour cardiovascular and denial training workouts a week.
Depression symptoms improved much more amid the patients in the 48-week group than among those in the 24-week group. This is vital because mood is often more debilitating than movement problems for Parkinson's patients, said study leader Dr Ariane Park, a action disorder neurologist at Ohio State University's Wexner Medical Center. The examination was published online recently in the journal Parkinsonism andamp; Related Disorders.
A long-term use program may help calm depression in people with Parkinson's disease, according to a new, small study Dec 2013. Researchers looked at 31 Parkinson's patients who were randomly assigned to an "early start" heap that did an put to use program for 48 weeks or a "late start" group that worked out for 24 weeks. The program included three one-hour cardiovascular and denial training workouts a week.
Depression symptoms improved much more amid the patients in the 48-week group than among those in the 24-week group. This is vital because mood is often more debilitating than movement problems for Parkinson's patients, said study leader Dr Ariane Park, a action disorder neurologist at Ohio State University's Wexner Medical Center. The examination was published online recently in the journal Parkinsonism andamp; Related Disorders.
Subscribe to:
Posts (Atom)